Multidrug-resistant Tuberculosis and its Implication with COVID-19

Mycobacterium tuberculosis is the leading cause of death due to pulmonary diseases and has developed resistance to various antibiotics over time making it extremely difficult to treat and eradicate. For an effective treatment regime, it becomes necessary to understand the factors and mechanisms of resistance to predict the possibility of associated resistance. In the present-day scenario, conditions of Tuberculosis patients have worsened due to COVID-19 with escalated mortality rates. Additionally, COVID-19 has also affected the regime and regular monitoring of patients which is mainly because of the shift in the focus and toxicity of various COVID-19 and Tuberculosis drug combinations.